UNC lab partnership develops first COVID-19 treatment approved by FDA

Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University. (Daily Tar Heel)

Related: Campus Connections

Honoring Chapel Hill’s Black Builders: UNC Landmarks and the Local Faces Who Built Them
Maps are storytellers, but they can exclude certain narratives. University of North Carolina graduate student Fowota Mortoo said that’s the case for Chapel Hill’s Black...
Mon Sep 8, 2025

'You'd really come home': Mama Dip's Kitchen closes after 49 years
Mildred Council opened Mama Dip’s Kitchen with $64 in 1976. After 49 years of serving the community as a local institution, the restaurant permanently shut...
Sat Sep 6, 2025

Memorial site dedicated to UNC professor Zijie Yan two years after shooting
Before his death, UNC associate professor Zijie Yan, a beloved teacher, colleague and friend, studied how to organize nanoparticles with light. On Thursday, exactly two...
Thu Sep 4, 2025

UNC’s architecture illustrates historical trends
With more than 250 buildings, the University’s evolution is reflected in the architectural styles spread across campus. In its earliest days, UNC consisted of just...
Tue Sep 2, 2025